Company: PCRX
Filing Date: 2025-08-05
Form Type: 10-Q
Source: 0001396814-25-000102
Chunk: 74

Company: Pacira BioSciences, Inc.
Filing Date: 2025-08-05
Form: 10-Q
Item: Part I, Item 1
Chunk 74
---
 may elect to contribute after-tax earnings to purchase shares at 85% of the closing fair market value of the Company’s common stock on either the offering date or the purchase date, whichever is lesser. During the six months ended June 30, 2025, 100,728 shares were purchased and issued through the ESPP.

NOTE 13—NET (LOSS) INCOME PER COMMON SHARE

Basic net (loss) income per common share is calculated by dividing the net (loss) income attributable to common shares by the weighted average number of common shares outstanding during the period. Diluted net (loss) income per common share is calculated by dividing the net (loss) income attributable to common shares by the weighted average number of common shares outstanding plus dilutive potential common shares outstanding during the period.Potential common shares include the shares of common stock issuable upon the exercise of outstanding stock options, the vesting of RSUs and the purchase of shares from the ESPP (using the treasury stock method), if applicable. Potential common shares associated with convertible senior notes are treated under the if-converted method. Adjustments are made to the diluted net (loss) income per common share calculation as if the Company had converted the convertible senior notes on the first day of each period presented. Adjustments to the numerator are made to add back the interest expense associated with the convertible senior notes on a post-tax basis. Adjustments to the denominator reflect the number of shares assumed to be convertible at the beginning of the period.

Pacira BioSciences, Inc.  |  Q2 2025 Form 10-Q  |  Page 29

Potential common shares are excluded from the diluted net (loss) income per common share computation to the extent they would be antidilutive. The following table sets forth the computation of basic and diluted net (loss) income per common share for the three and six months ended June 30, 2025 and 2024 (in thousands, except per common share amounts):Three Months EndedJune 30,Six Months EndedJune 30,2025202420252024Numerator:   Net (loss) income—basic$(4,847)$18,886 $(35)$27,865 2025 Notes if-converted method adjustment— 762 — 1,790    Adjusted net (loss) income—diluted$(4,847)$19,648 $(35)$29,655 Denominator:   Weighted average common shares outstanding—basic